Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT04670536Completed

The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems (PASS DEGEN)

Role: lead

NCT04547959Not ApplicableCompleted

Prospective Clinical Study to Evaluate the Efficacy of the Stand-alone Cervical Interbody Cage C-CURVE ( Titanium) Manufactured by MEDICREA®

Role: lead

NCT02926404Terminated

UNiD Rods Register

Role: lead

NCT02931279Completed

PASS OCT® Post-market Clinical Follow-up

Role: lead

NCT02931266Terminated

PASS MIS® Post-market Clinical Follow-up

Role: lead

NCT02926391Completed

UNiD 3D VBR Register

Role: lead

NCT01635322Completed

Sagittal Plane Correction With Pass-LP Device in Adult Deformity Patients

Role: lead

NCT01518582Completed

GRANVIA®-C Cervical Disc Prosthesis Multicenter European Pilot Study

Role: lead

All 8 trials loaded